market

Arcutis shares rally in after-hours trading on FDA approval


FDA approved concept. Rubber stamp with FDA and medicine.

Bet_Noire

Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) rallied 20% in after-hours trading Friday on news that the FDA had approved the company’s drug Zoryve, also known as roflumilast, for the treatment of seborrheic dermatitis in people aged 9 years or older.

The



READ SOURCE

Readers Also Like:  Sensex ends above 72,000 mark for first time; Nifty above 21,650; HUDCO soars 9%, UltraTech 4%

This website uses cookies. By continuing to use this site, you accept our use of cookies.